Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06742944 · ClinicalTrials.gov registry record
Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217
A clinical trial, sponsored by Banner Health.
- Completed
- Registry status
- 100
- Enrollment target
NCT06742944: Completed study, sponsored by Banner Health.
NCT06742944 is a clinical trial that has completed, run by Banner Health. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06742944 has completed, sponsored by Banner Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is an observational study that will serially collect 10 plasma samples over the course of 9 weeks from the same individuals to assess fluctuations in blood biomarker results.
Primary Outcome
Assess within participant changes in plasma pTau217 biomarker assay levels over the course of the study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2025-11-30 |
What the finished NCT06742944 record still lists
NCT06742944 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06742944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06742944 about?
NCT06742944 is a clinical study titled "Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217". This is an observational study that will serially collect 10 plasma samples over the course of 9 weeks from the same individuals to assess fluctuations in blood biomarker results.
What is the current status of trial NCT06742944?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2025-01-27. Estimated completion is 2025-11-30.
Who is sponsoring clinical trial NCT06742944?
This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI